Artículos por temáticas

Spontaneous swallowing frequency in the evaluation of swallowing function

Guidotti L, Españo D, Tomsen N, Clavé P, Ortega O.

Expert Rev Gastroenterol Hepatol. 2025 Sep;19(9):985-1005. doi: 10.1080/17474124.2025.2550525. Epub 2025 Sep 1.

Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults

Chahine L, Rosso AL, Troidl I, Ganguli M, Newman AB, Lopresti BJ, Allen K, Royse SK, Mosovsky S, Ratner E, Dholakia G, Bohnen NI, Rosano C.

Neurology. 2025 Sep 23;105(6):e214037. doi: 10.1212/WNL.0000000000214037. Epub 2025 Aug 29.

An update on the involvement of inflammatory mediators in Parkinson's disease pathogenesis

Verma O, Faizan M, Goswami S, Singh MP.

Arch Toxicol. 2025 Sep;99(9):3527-3552. doi: 10.1007/s00204-025-04088-y. Epub 2025 Jun 3.

The on-going quest for a long-acting oral form of levodopa

Teil M, Al-Kassmy J, Alsalmi M, Al-Rawahi B, Huot P.

Expert Opin Drug Metab Toxicol. 2025 Sep;21(9):1049-1058. doi: 10.1080/17425255.2025.2535177. Epub 2025 Jul 20.

Impact of Subthalamic Nucleus Deep Brain Stimulation on Gastrointestinal Symptoms and Gastric Emptying in Parkinson's Disease: A Systematic Review and Meta-Analysis

Abbas A, Sabet H, Hawas Y, Yousef O, Kassar O, AbdelMeseh M, Khatatbeh AA, Lashin B, Awad H, Cloud LJ, Negida A, Raslan AM.

Neuromodulation. 2025 Sep 4:S1094-7159(25)00274-0. doi: 10.1016/j.neurom.2025.07.005. Online ahead of print.

Cognitive and neuropathological contributions to gait dysfunction in Parkinson's disease

Iqbal A, Ahmad B, Ahmad A, Iqbal T, Fazal T.

Parkinsonism Relat Disord. 2025 Sep;138:107868. doi: 10.1016/j.parkreldis.2025.107868. Epub 2025 May 12.

Glucagon-Like Peptide-1 Receptor Agonists in Neurodegenerative Diseases: A Comprehensive Review

Ibrahim R, Kambal A, Abdelmajeed MA.

Cureus. 2025 Sep 16;17(9):e92441. doi: 10.7759/cureus.92441. eCollection 2025 Sep.

The membrane receptor CD44: roles in neurodegenerative diseases

Zhang M, Lin Y, Wei H, Ju Q, Gao T, Zhang Y, Shen L, Sun C.

Expert Opin Ther Targets. 2025 Sep 21:1-10. doi: 10.1080/14728222.2025.2563243. Online ahead of print.

TRX/TXNIP/miRs network in neuronal cells and TXNIP-targeted miRs modulate neuroinflammation, neuronal apoptosis, and mitochondrial dysfunction in Parkinson's disease: A review

Panda SP, Singh V, Kumar S, Chaitanya MVNL, Singh M, Shanmugam R, Shakya PK, Tatiparthi R, Thapliyal S, Chaubey KK, Chahal A, Sidiq M, Prasad PD, Jha NK.

Int J Biol Macromol. 2025 Sep;322(Pt 2):146878. doi: 10.1016/j.ijbiomac.2025.146878. Epub 2025 Aug 13.

Advances in transcranial magnetic stimulation for psychological symptom management in Parkinson's disease

Zhou XL, Li Y, Xia W, Zheng YY, Wu AP.

World J Psychiatry. 2025 Sep 19;15(9):108497. doi: 10.5498/wjp.v15.i9.108497. eCollection 2025 Sep 19.

Profiling the landscape of cysteine posttranslational modifications in brain aging and neurodegeneration

Filipovic MR.

Neurotherapeutics. 2025 Aug 30:e00726. doi: 10.1016/j.neurot.2025.e00726. Online ahead of print.

Interplay between exercise and neuregulin in providing neuroprotection

Sharma J, Thakur A, Rain M, Khosla R, Maity K, Mathur GR, Anand A.

Behav Brain Res. 2025 Sep 13;493:115710. doi: 10.1016/j.bbr.2025.115710. Epub 2025 Jun 24.

Understanding the progression of Parkinson's disease: a review

Kempster PA.

BMJ Neurol Open. 2025 Sep 8;7(2):e001215. doi: 10.1136/bmjno-2025-001215. eCollection 2025.

Cognitive behavioral therapy for anxiety and depression symptoms in people of Parkinson's disease: a systematic review and meta-analysis

Yu X, Wu Q, Liu Y, Han P, Chen X, Guo Q.

Front Aging Neurosci. 2025 Sep 5;17:1440850. doi: 10.3389/fnagi.2025.1440850. eCollection 2025.

Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light

Maleeva G, Matera C, Roda S, Colleoni A, De Amici M, Gorostiza P.

Med Res Rev. 2025 Sep;45(5):1407-1422. doi: 10.1002/med.22112. Epub 2025 Apr 10.